Volume 76, Issue 2, Pages (July 2009)

Slides:



Advertisements
Similar presentations
Telomerase deficiency delays renal recovery in mice after ischemia–reperfusion injury by impairing autophagy Huifang Cheng, Xiaofeng Fan, William E. Lawson,
Advertisements

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.
Navdeep Tangri, Paul V.J. Komenda, Claudio Rigatto 
Figure 6 Effects of adiponectin on podocyte function
Renal manifestations in Fabry disease and therapeutic options
Propofol-related green urine
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
Volume 83, Issue 3, Pages (March 2013)
Obesity, inflammation, and kidney disease
Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007  Joanna M. Smith, Susan A. Mott,
Reassessment of the care of the patient with chronic kidney disease
John P. Middleton, Patrick H. Pun  Kidney International 
Volume 77, Issue 1, Pages 6-8 (January 2010)
Burden of chronic kidney disease: North Africa
Volume 85, Issue 3, Pages (March 2014)
IKKɛ: A Bridge between Obesity and Inflammation
End-stage renal disease in living kidney donors
Volume 71, Issue 2, Pages (January 2007)
Ian H. de Boer, Rajnish Mehrotra  Kidney International 
Volume 77, Issue 1, Pages 5-6 (January 2010)
Methotrexate in the urine
Comorbidity and confounding in end-stage renal disease
Volume 74, Issue 3, Pages (August 2008)
Lipid redistribution in renal dysfunction
Volume 70, Issue 11, Pages (December 2006)
Volume 76, Issue 11, Pages (December 2009)
Nephrology Crosswords: Hemodialysis
Use of vitamin D in chronic kidney disease patients
Pieter Evenepoel, Björn K. Meijers  Kidney International 
Volume 71, Issue 6, Pages (March 2007)
Volume 70, Issue 12, Pages (December 2006)
Fructose intake as a risk factor for kidney stone disease
Response to ‘Hepcidin levels in patients with renal disease’
Volume 73, Issue 12, Pages (June 2008)
Volume 83, Issue 4, Pages (April 2013)
Volume 76, Issue 6, Pages (September 2009)
Capturing the in vivo molecular signature of the podocyte
A physician's perseverance uncovers problems in a key nephrology study
Navdeep Tangri, Paul V.J. Komenda, Claudio Rigatto 
Extracorporeal therapy in sepsis: are we there yet?
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
Volume 74, Issue 8, Pages (October 2008)
Nephrology Crossword: Peritoneal Dialysis
Calcium sensing in podocytes
Methods for guideline development
Volume 87, Issue 1, Pages (January 2015)
Atrial fibrillation in end-stage renal disease: an emerging problem
Nephrology Crossword: Glomerulonephritis
Unilateral renal cystic disease
Insulin resistance and hypertension: new insights
Circadian regulation of renal function
Volume 73, Issue 9, Pages (May 2008)
Volume 82, Issue 7, Pages (October 2012)
Volume 82, Issue 9, Pages (November 2012)
Volume 83, Issue 5, Pages (May 2013)
Volume 80, Issue 10, Pages (November 2011)
Cardiovascular risk in chronic kidney disease
Volume 76, Issue 1, Pages 8-10 (July 2009)
Is complement a target for therapy in renal disease?
Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller 
Volume 75, Issue 7, Pages (April 2009)
James B. Young, Hans-Hellmut Neumayer, Robert D. Gordon 
Membranous nephropathy: recent travels and new roads ahead
Adiponectin: good, bad, or just plain ugly?
The international realities of live donor kidney transplantation
Renal dysfunction in cirrhosis is not just a vasomotor nephropathy
Ronen Levi, Justin Silver  Kidney International 
Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies  Lei-Shi Li, Zhi-Hong Liu  Kidney International 
Presentation transcript:

Volume 76, Issue 2, Pages 145-148 (July 2009) The link between obesity and albuminuria: adiponectin and podocyte dysfunction  Kumar Sharma  Kidney International  Volume 76, Issue 2, Pages 145-148 (July 2009) DOI: 10.1038/ki.2009.137 Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 1 Potential links between adiposity, kidney response, and cardiovascular disease. With increasing fat mass, visceral adipocytes decrease the production of circulating adiponectin and increase the production of adipokines that enhance insulin resistance. The lower adiponectin levels lead to impaired podocyte function, possibly because of increased podocyte NADPH oxidase. Podocyte dysfunction will lead to albuminuria and increased levels of hydrogen peroxide in the urine. The increased production of hydrogen peroxide from renal NADPH oxidase could potentially cause hydrogen peroxide to enter the circulation, contributing to the systemic inflammation that accompanies low-grade albuminuria. Kidney International 2009 76, 145-148DOI: (10.1038/ki.2009.137) Copyright © 2009 International Society of Nephrology Terms and Conditions